可治疗的特征作为喘缓解的途径
Inês Farinha1, Peter G Gibson2, Vanessa M McDonald2
1Pulmonology Department, Local Health Unit of the Leiria Region, Rua das Olhalvas - Pousos 2410-197 Leiria, Portugal.
概括
喘治疗目标正在向缓解转移,缓解的定义是缺少症状和至少一年改善肺功能. 目标化 目标化 目标化 目标化
科学领域:
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 改变疾病的抗喘药物促使人们重新评估喘治疗目标.
- 现在,喘的临床缓解被认为是可以实现的目标.
研究的目的:
- 提出一种新的方法来实现喘缓解.
- 突出"可治疗特征"在个性化喘管理中的潜力.
主要方法:
- 确定喘临床缓解标准 (没有症状,没有发作,没有全身皮质类固醇,稳定的肺功能12个月以上).
- 为个性化治疗策略引入"超级特征"的概念.
- 建议使用肺,肺外和行为可治疗的特征.
主要成果:
- 喘缓解的特点是持续缺乏症状,发作和全身使用皮质类固醇,以及改善肺功能.
- "可治疗特征"方法为个性化的慢性呼吸道疾病管理提供了一个多维策略.
- 整合肺,肺外和行为特征可以引导治疗向缓解.
结论:
- 喘缓解是一个可行的和雄心勃勃的治疗目标.
- 通过"可治疗特征"进行个性化医疗是实现喘缓解的关键.
- 针对肺,肺外和行为因素的综合方法对于成功的喘缓解至关重要.
更多相关视频
相关概念视频
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
234
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
234
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Leukotriene Modifiers
151
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
151
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
161
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
161
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K


